Table of Contents  by unknown
Vol. 137, No. 6, June 2009
Table of Contents
Presidential Obituary 1307 David C. Sabiston, Jr, MD
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1317 Weathering the storm: How can thoracic surgery training programs meet
the new challenges in the era of less-invasive technologies?
Sunil M. Prasad, MD, Malek G. Massad, MD, Edgar G. Chedrawy, MD, Norman J. Snow, MD,
Joannie T. Yeh, MS, Himalaya Lele, MD, Ahmed Tarakji, MD, Hersh S. Maniar, MD,
Heather Herren, RN, MPH, and William A. Gay, MD, Chicago, Ill, Newark, Del, and
St Louis, MO
The introduction of new technologies has affected the role of cardiothoracic surgeons and their
training. We examined the operative case volume from 2002 to 2007 to identify these changes and
trends. Many core operative procedures in cardiac surgery have significantly changed and there is an
advantage in case volume in 3-year programs.
Congenital Heart
Disease (CHD)
1327 Cardiovascular surgery in children with Marfan syndrome or Loeys-Dietz
syndrome
Melanie D. Everitt, MD, Nelangi Pinto, MD, John A. Hawkins, MD, Max B. Mitchell, MD,
Peter C. Kouretas, MD, and Anji T. Yetman, MD, Salt Lake City, Utah, and Denver, Colo
We reviewed the frequency and outcome of cardiovascular surgery performed in childrenwithMarfan
or Loeys-Dietz syndrome. Aortic valve-sparing root replacement and use of angiotensin-converting
enzyme inhibitors postoperatively were associated with a lower risk of reintervention.
1334 Analysis of the US Food and Drug Administration Manufacturer and User
Facility Device Experience database for adverse events involving Amplatzer
septal occluder devices and comparison with the Society of Thoracic Surgery
congenital cardiac surgery database
Daniel J. DiBardino, MD, Doff B. McElhinney, MD, Aditya K. Kaza, MD, and
John E. Mayer, Jr, MD, Boston, Mass
Using the results of the MAUDE database for device adverse events and estimating a denominator
based on published literature, we compare the results of Amplatzer device atrial septal defect closure
versus the Society of Thoracic Surgery results for open surgical closure during the same time period.
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CPS1342 Differential branch pulmonary artery growth after the Norwood procedure
with right ventricle–pulmonary artery conduit versus modified
Blalock–Taussig shunt in hypoplastic left heart syndrome
Jay D. Pruetz, MD, Sarah Badran, MD, Fred Dorey, PhD, Vaughn A. Starnes, MD, and
Alan B. Lewis, MD, Los Angeles, Calif
This study compared PA growth after the Norwood procedure with mBTS versus RV–PA conduit.
The RV–PA conduit promoted better and more balanced branch PA growth but resulted in central PA
hypoplasia. Worsening cyanosis from conduit stenosis often led to additional shunting or early Glenn
anastomosis in patients with an RV–PA conduit.
1349 Inferior sinus venosus defect: Echocardiographic diagnosis and
surgical approach
Matthew A. Crystal, MD, Khaled Al Najashi, MD, William G. Williams, MD,
Andrew N. Redington, MD, and Robert H. Anderson, MD, Toronto, Ontario,
Canada, and London, United Kingdom
We report all children shown at surgical correction to have an inferior sinus venosus defect, which is
defined as anomalous pulmonary venous drainage to the inferior caval vein with retention of the
pulmonary venous connection to the left atrium. This lesion can easily be repaired, correctly
redirecting the anomalous venoatrial connections.
1356 Myocyte apoptosis occurs early during the development of pressure-overload
hypertrophy in infant myocardium
Yeong-Hoon Choi, MD, Douglas B. Cowan, PhD, Adrian M. Moran, MBBS, Steven D. Colan, MD,
Christof Stamm, MD, Koh Takeuchi, MD, Ingeborg Friehs, MD, Pedro J. del Nido, MD, and
Francis X. McGowan, Jr, MD, Boston, Mass
This study examined the hypothesis that myocyte loss occurs during compensatory hypertrophic
growth in the developing infant myocardium subjected to progressive pressure overload. In
experimental infant LV hypertrophy, myocyte apoptosis is initiated in the face of normalized wall
stress and preserved contractility. It thus appears that pressure overload, even at its earliest stages,
is not well tolerated by the developing ventricle.
1363 Use of a novel valve stent for transcatheter pulmonary valve replacement:
An animal study
Gang-Jun Zong, MD, PhD, Yuan Bai, MD, Hai-Bin Jiang, MD, Wei-Ping Li, MD, PhD,
Hong Wu, MD, PhD, Xian-Xian Zhao, MD, PhD, and Yong-Wen Qin, MD, PhD,
Shanghai, China
We examined valvular function after transcatheter pulmonary valve replacement in sheep using
a novel pulmonary valve stent. The stent was constructed by suturing porcine pericardium
cross-linked with glutaraldehyde onto a valve ring. At 6 months, there was no evidence
of valve stent dislocation, and valvular and cardiac functions were normal.
(continued on page 18A)
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General Thoracic
Surgery (GTS)
1370 Thoracoscopic sympathetic clipping for hyperhidrosis: Long-term results
and reversibility
Hiroshi Sugimura, MD, Ernest H. Spratt, MD, Christopher G. Compeau, MD, Deepa Kattail,
and Yaron Shargall, MD, Toronto, Ontario, Canada
Over a period of 8 years, 727 patients underwent bilateral endoscopic thoractic sympathetic clipping.
Excellent patient satisfaction was seen mostly in the T314 clipping group when compared with the
T2 or T213 groups (P, .01) with less compensatory sweating and less need for reversal procedure.
Of 34 reversal procedures (mainly for compensatory sweating), 48% had significant improvement
and 42% remained free of their original symptoms.
1379 Superior sulcus tumors with vertebral body involvement: A multimodality
approach
William D. Bolton, MD, David C. Rice, MD, Adam Goodyear, MD, Arlene M. Correa, PhD,
Jeremy Erasmus, MD, Wayne Hofstetter, MD, Ritsuko Komaki, MD, Reza Mehran, MD,
Katherine Pisters, MD, Jack A. Roth, MD, Stephen G. Swisher, MD, Ara A. Vaporciyan, MD,
Garrett L. Walsh, MD, Jason Weaver, MD, and Laurence Rhines, MD, Houston, Tex
Surgical resection for patients with superior sulcus tumors and vertebral involvement can be
performed with an acceptable morbidity in highly selected patients. This requires an aggressive
multimodality approach performed only at specialized centers. Encouraging long-term survival
can be achieved in patients with negative margins and no lymph node involvement.
1388 Thoracoscopic segmentectomy compares favorably with thoracoscopic
lobectomy for patients with small stage I lung cancer
Mark Shapiro, MD, Todd S. Weiser, MD, Juan P. Wisnivesky, MD, MPH, Cynthia Chin, MD,
Michael Arustamyan, BA, and Scott J. Swanson, MD, New York, NY, and Boston, Mass
Review of 31 patients after VATS segmentectomy and 113 after VATS lobectomy showed that
thoracoscopic segmentectomy is a safe option for patients with small stage I lung cancer, without
significant difference in oncologic outcome. Furthermore, lymph node dissection can be performed as
effectively during VATS segmentectomy as during VATS lobectomy.
1394 A prospective study of the association between drainage volume within
24 hours after thoracoscopic lobectomy and postoperative morbidity
Ryoichi Nakanishi, MD, PhD, Yoshihisa Fujino, MD, MPH, PhD, Toshihiro Yamashita, MD,
and Soichi Oka, MD, Kitakyusyu, Japan
We prospectively analyzed the association between drainage volume and complications to clarify the
safety of early removal of chest tubes after thoracoscopic lobectomy in 136 patients. Chest tube
removal on the day after surgery appears to be safe in well-selected patients because we found no
association between these factors.
1400 Lobectomy with pulmonary artery resection: Morbidity, mortality, and
long-term survival
Marco Alifano, MD, Giacomo Cusumano, MD, Salvatore Strano, MD, Pierre Magdeleinat, MD,
Antonio Bobbio, MD, Frederique Giraud, MD, Bernard Lebeau, MD, and
Jean-Franc¸ois Re´gnard, MD, Paris, France
A retrospective study of lobectomy with pulmonary artery resection is presented. Indications and
techniques of tangential and circumferential artery resection and reconstruction are detailed. Morbidity
and mortality figures indicate no specific complications related to the procedures. The overall 5-year
survival among patients undergoing operations for non–small cell lung cancer was 34.9%.
(continued on page 20A)
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1406 The normal configuration and interindividual differences in intramural
lymphatic vessels of the esophagus
Shinji Yajin, MD, Gen Murakami, MD, PhD, Hiromi Takeuchi, MD, PhD, Tadashi Hasegawa, MD,
PhD, and Hiroya Kitano, MD, PhD, Yonago, Iwamizawa, and Sapporo, Japan
To clarify normal configuration of the esophageal intramural lymphatics, D2-40
immunohistochemical staining for human lymphatic epithelium was performed at three sites in
the cervical and thoracic esophagus in 16 donated cadavers without macroscopic malignancy or
chronic inflammation. Interindividual differences in lymphatic vessel density were more than
2-fold.
1415 Safety and efficacy of video-assisted versus conventional lung resection for
lung cancer
Farhood Farjah, MD, MPH, Douglas E. Wood, MD, Michael S. Mulligan, MD,
Bahirathan Krishnadasan, MD, Patrick J. Heagerty, PhD, Rebecca Gaston Symons, MPH, and
David R. Flum, MD, MPH, Seattle, Wash
Using Surveillance, Epidemiology, and End-Results Medicare data, 6% of patients with lung cancer
who underwent a lobectomy/segmentectomy did so through video-assisted thoracoscopy (VATS).
The use of VATS increased over a 9-year period. After adjustment, long-term survival associated
with VATS was equivalent to that of open resection, and 30-day fatality rates were not significantly
different.
Acquired Cardiovascular
Disease (ACD)
1422 Surgery for aortic and mitral valve disease in the United States: A trend of
change in surgical practice between 1998 and 2005
Scott D. Barnett, PhD, and Niv Ad, MD, Falls Church, Va
The surgical treatment of valvular heart disease has changed significantly in the past decade with
more mitral valves being repaired and tissue valves implanted in the aortic position. The surgical
treatment for mitral disease has transitioned to primarily one of repair, not replacement, with the use
of bioprosthesis more than doubling.
1430 Characterization and outcome of patients with severe symptomatic aortic
stenosis referred for percutaneous aortic valve replacement:
Samir R. Kapadia, MD, FACC, Sachin S. Goel, MD, Lars Svensson, MD, PhD, Eric Roselli, MD,
Robert M. Savage, MD, Lee Wallace, MD, Srikanth Sola, MD, FACC, Paul Schoenhagen, MD,
FACC, Mehdi H. Shishehbor, DO, MPH, Ryan Christofferson, MD, Carmel Halley, MD,
L. Leonardo Rodriguez, MD, FACC, William Stewart, MD, FACC, Vidyasagar Kalahasti, MD, FACC,
and E. Murat Tuzcu, MD, FACC, Cleveland, Ohio
Patients at high surgical risk with symptomatic severe aortic stenosis are being referred for
percutaneous aortic valve replacement. They have high mortality if timely aortic valve replacement is
not feasible. Substantial numbers of these patients referred for percutaneous aortic valve replacement
can undergo surgical aortic valve replacement. Patients managed with balloon aortic valvuloplasty or
without any intervention have unfavorable outcomes.
(continued on page 22A)
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1436 Impact of preconditioning protocol on anesthetic-induced cardioprotection in
patients having coronary artery bypass surgery
Jan Fra¨ßdorf, MD, Andreas Borowski, MD, Dirk Ebel, MD, Peter Feindt, MD, Manuel Hermes, MD,
Thomas Meemann, MD, Rene´ Weber, MD, Jost Mu¨llenheim, MD, DEAA, Nina C. Weber, PhD,
Benedikt Preckel, MD, MA, DEAA, and Wolfgang Schlack, MD, DEAA, Amsterdam,
The Netherlands, Duesseldorf, Germany, and South Shields, United Kingdom
In this clinical investigation, we demonstrate that anesthetic-induced preconditioning by sevoflurane
exists in patients having coronary artery bypass surgery. This effect depends on the preconditioning
protocol used.
1443 Mild chronic kidney dysfunction and treatment strategies for stable coronary
artery disease
Neuza Helena Lopes, MD, PhD, Felipe da Silva Paulitsch, MD, Alexandre Pereira, MD, PhD,
Cibele Larossa Garzillo, MD, Joa˜o Fernando Ferreira, MD, PhD, Noedir Stolf, MD, PhD, and
Whady Hueb, MD, PhD, Sa˜o Paulo, Brazil
Our study evaluates the association of chronic kidney dysfunction in patients with multivessel
chronic CAD. Our results confirm that CAD accompanied by chronic kidney dysfunction has a worse
prognosis and, according to the range of estimated glomerular filtration rate strata, different treatment
strategies may have differential beneficial effects.
1450 Open distal anastomosis in aortic root replacement using axillary cannulation
and moderate hypothermia
Hiroo Takayama, MD, Craig R. Smith, MD, Michael E. Bowdish, MD, and Allan S. Stewart, MD,
New York, NY
Retrospective review of our 136 consecutive patients who had aortic root replacement with axillary
artery cannulation and moderate hypothermia showed that open distal anastomosis can safely be
performed with this strategy and that axillary cannulation provides a reliable route of antegrade
cerebral perfusion.
1454 Outcomes after surgical resection of cardiac sarcoma in the multimodality
treatment era
Faisal G. Bakaeen, MD, Dawn E. Jaroszewski, MD, David C. Rice, MD, Garret L. Walsh, MD,
Ara A. Vaporciyan, MD, Steven S. Swisher, MD, Robert Benjamin, MD, Shanda Blackmon, MD,
and Michael J. Reardon, MD, Houston, Tex
Multimodal therapy for primary cardiac sarcoma can achieve reasonable survival for selected
patients. Patients with local tumor recurrence or metastatic disease may still benefit from an
aggressive treatment regimen.
1461 The effect of biventricular pacing after coronary artery bypass grafting:
A prospective randomized trial of different pacing modes in patients
with reduced left ventricular function
Frank Eberhardt, MD, Matthias Heringlake, MD, Maximilian S. Massalme, MD, Anika Dyllus, MD,
Martin Misfeld, MD, PhD, Hans-H. Sievers, MD, Uwe K. H. Wiegand, MD, and
Thorsten Hanke, MD, Lu¨beck, Germany
Biventricular perioperative pacing acutely improves left ventricular function in patients with left heart
failure undergoing coronary artery bypass grafting. These benefits do not translate into improved
postoperative hemodynamics or clinical outcome relative to conventional atrioventricular universal
or atrial inhibited pacing.
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1468 Influence of body mass index on the efficacy of revascularization in patients with
coronary artery disease
Aslan T. Turer, MD, Kenneth W. Mahaffey, MD, Emily Honeycutt, MBI, Robert H. Tuttle, MSPH,
Linda K. Shaw, MS, Michael H. Sketch, Jr, MD, Peter K. Smith, MD, Robert M. Califf, MD, and
John H. Alexander, MD, MHS, Durham, NC
We examined the effect of BMI on the association between revascularization strategy and survival in
patients with CAD. Extremes of BMI are associated with lower long-term survival in patients with
significant CAD. Revascularization, particularly with CABG, is consistently associated with the best
survival across the spectrum of BMI.
1475 Surgical treatment of multivalvular endocarditis: Twenty-one–year single
center experience
Feng Yao, MD, Lin Han, MD, Zhi-yun Xu, MD, Liang-jian Zou, MD, Sheng-dong Huang, MD,
Zhi-nong Wang, MD, Fang-lin Lu, MD, and Ying-long Yao, MD, Shanghai,
People’s Republic of China
MVE was diagnosed by TTE in only half of our patients. Intraoperative TEE provided a more
effective means to identify this disease. Radical resection of all infected tissues and additional
intraoperative interventions, depending on the intraoperative pathologic condition, produced
satisfactory in-hospital and long-term results similar to those in patients with a single infected
heart valve.
1481 Minimally invasive video-assisted mitral valve surgery: A 12-year, 2-center
experience in 1178 patients
Paul Modi, MD, FRCS, Evelio Rodriguez, MD, FACS, W. Clark Hargrove III, MD, FACS,
Ansar Hassan, MD, PhD, Wilson Y. Szeto, MD, FACS, and W. Randolph Chitwood, Jr, MD, FACS,
FRCS, Greenville, NC, and Philadelphia, Pa
Over a 12-year period, we performed 1178 minimally invasive video-assisted mitral valve (MV)
procedures with operative mortalities for MV repair and replacement of 2.1% and 4.6%, and for
isolated primary MV repair and replacement of 0.2% and 3.6%, respectively. Preoperative atrial
fibrillation but not prior cardiac surgery was a significant predictor of mortality.
Cardiothoracic
Transplantation (TX)
1488 Surgical revascularization for cardiac allograft vasculopathy: Is it still
an option?
Jay K. Bhama, MD, Duc Q. Nguyen, MD, Sun Scolieri, MD, Jeffrey J. Teuteberg, MD,
Yoshiya Toyoda, MD, PhD, Robert L. Kormos, MD, Kenneth R. McCurry, MD,
Dennis McNamara, MD, and Christian A. Bermudez, MD, Pittsburgh, Pa
Cardiac allograft vasculopathy remains a major cause of mortality after cardiac transplantation with
historically poor outcomes following surgical revascularization. We report outcomes of coronary
artery bypass grafting in 13 patients demonstrating that surgical revascularization remains a viable
treatment option for appropriately selected patients.
(continued on page 26A)
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1493 Prolonged venoarterial extracorporeal membrane oxygenation after
transplantation restores functional integrity of severely injured lung
allografts and prevents the development of pulmonary graft failure
in a pig model
Gyo¨rgy Lang, MD, Clemens Aigner, MD, Gu¨nther Winkler, MD, Keso Shkirdladze, MD,
Wilfried Wisser, MD, Gerhard Dekan, MD, Masaya Tamura, MD, Georg Heinze, PhD,
Dirk Van Raemdonck, MD, and Walter Klepetko, MD, Vienna, Austria, and
Leuven, Belgium
This study addresses the use of prolonged extracorporeal membrane oxygenation (ECMO) in lung
transplantation. A smooth reperfusion period combined with gentle ventilation can prevent the
development of pulmonary graft dysfunction, even in severely impaired lungs. ECMO offers
a unique opportunity to realize this concept. This approach could help to expand the use of
marginal donors.
Evolving Technology (ET) 1499 Keratinocyte growth factor accelerates compensatory growth in the remaining
lung after trilobectomy in rats
Keitaro Matsumoto, MD, Takeshi Nagayasu, MD, Yoshitaka Hishikawa, MD, Tsutomu Tagawa, MD,
Takatomo Yamayoshi, MD, Takafumi Abo, MD, Shuichi Tobinaga, MD, Katsuro Furukawa, MD,
and Takehiko Koji, PhD, Nagasaki, Japan
Keratinocyte growth factor (KGF) is a member of fibroblast growth factor family. In rats subjected to
trilobectomy, proliferating cell nuclear antigen, KGF, and KGF receptor were overexpressed in lung
epithelial cells of the remaining lung 4 days later. KGF gene transfection by means of electroporation
in the remaining lung significantly augmented epithelial proliferation and reduced the average
airspace distance.
1508 Selective phosphodiesterase-5 inhibition reduces neointimal hyperplasia in rat
carotid arteries after surgical endarterectomy
Kristo´f Hirschberg, MD, Tama´s Radovits, MD, PhD, Sivakkanan Loganathan, La´szlo´ Entz, MD,
PhD, Carsten J. Beller, MD, Marie–Luise Gross, MD, Peter Sandner, PhD, Matthias Karck, MD,
and Ga´bor Szabo´, MD, PhD, Heidelberg and Wuppertal, Germany, and Budapest, Hungary
In a rat model of carotid endarterectomy, we investigated the effects of the pharmacologic inhibition
of cyclic guanosine monophosphate degradation on neointima formation by using the novel selective
phosphodiesterase-5 inhibitor vardenafil. Three weeks after in vivo endothelial denudation, we found
a significant decrease in neointimal/medial area ratio and neointimal transforming growth factor b1
and a-smooth muscle actin expression.
1515 Plasma transforming growth factor b1 as a biochemical marker to predict the
persistence of atrial fibrillation after the surgical maze procedure
Young Keun On, MD, PhD, Eun-Seok Jeon, MD, PhD, Sang Yeub Lee, MD, Dae-Hee Shin, MD,
Jin-Oh Choi, MD, Jidong Sung, MD, MPH, June Soo Kim, MD, PhD, Kiick Sung, MD, and
PyoWon Park, MD, PhD, Seoul, Korea
Preoperative plasma transforming growth factor b1 levels could be used to predict the persistence
of atrial fibrillation and correlated with the degree of fibrosis in the left atria of patients with mitral
valvular heart disease.
(continued on page 28A)
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Cardiopulmonary
Support (CPS)
1521 Optimal dose of aprotinin for neuroprotection and renal function in a piglet
survival model
Yusuke Iwata, MD, Toru Okamura, MD, Nobuyuki Ishibashi, MD, David Zurakowski, PhD,
Hart G. W. Lidov, MD, and Richard A. Jonas, MD, Washington, DC
Aprotinin significantly improves neurologic scores on postoperative day 1 after ultra–low-flow
bypass at 25C or 34C (P , .01) but not after hypothermic circulatory arrest (P 5 .57). Linear
regression indicates a strong dose-response relationship. During low-flow bypass, a higher tissue
oxygenation index correlates with a higher aprotinin dose (P , .05). Aprotinin has no significant
effect on creatinine.
1530 Pulmonary injury after cardiopulmonary bypass: Beneficial effects of
low-frequency mechanical ventilation
Hajime Imura, MD, Massimo Caputo, MD, Kelvin Lim, FRCS, Masami Ochi, MD,
M-Saadeh Suleiman, DSc, Kazuo Shimizu, MD, and Gianni D. Angelini, FRCS,
Tokyo, Japan, and Bristol, United Kingdom
Lung dysfunction is a known complication after heart surgery with CPB. We provide evidence in an
experimental pig model that low-frequency ventilation during CPB reduces lung metabolic and
histologic damage and improves postoperative oxygenation. The technique is safe and simple and can
be readily applied in clinical practice.
1538 Regression of flow-induced pulmonary arterial vasculopathy after flow
correction in piglets
Olaf Mercier, MD, Edouard Sage, MD, Marc de Perrot, MD, Ly Tu, BSc, Elisabeth Marcos, BSc,
Benoıˆt Decante, MSc, Bruno Baudet, BSc, Philippe Herve´, MD, Philippe Dartevelle, MD,
Saadia Eddahibi, PhD, and Elie Fadel, MD, Le Plessis-Robinson, France
In chronic thromboembolic pulmonary hypertension, vasculopathy is induced in the unobstructed
arterial bed by pulmonary overflow. We found that endothelin-1, its receptor ETA, and angiopoietin
receptor Tie-2 play a major role in the development of this overflow-induced vasculopathy, becoming
thus therapeutic targets before pulmonary endarterectomy.
Brief Communications:
Clinical
1547 Mitral valve injury late after transcatheter aortic valve implantation
Daniel R. Wong, MD, MPH, Robert H. Boone, MD, MSc, Christopher R. Thompson, MD,
Michael F. Allard, MD, Lukas Altwegg, MD, Ronald G. Carere, MD, Anson Cheung, MD,
Jian Ye, MD, Samuel V. Lichtenstein, MD, PhD, Hilton Ling, MD, and John G. Webb, MD,
Vancouver, British Columbia, Canada
1549 A new subspecialty in cardiac surgery: Scrap metal merchant
Giuseppe Rescigno, MD, Marco Pozzi, MD, FRCS, FETCS, Filippo Capestro, MD,
Luciano S. Matteucci, MD, Christopher Mu¨nch, MD, Gianfranco Iacobone, MD, and
Gian Piero Piccoli, MD, Ancona, Italy
1551 Concomitant bilateral lung volume reduction surgery and aortic valve
replacement: Multidisciplinary strategies in achieving a successful outcome
Cliff K. Choong, FRCS, FRACS, Yasir Abu-Omar, DPhil, MRCS, Ajit Agarwal, FRCP,
Thomas Pulimood, FRCP, Nicholas Screaton, FRCR, Ian Hardy, FRCA,
Alain Vuylsteke, PhD, FRCA, and Michael Davies, FRCP, Cambridge and
Bury St Edmunds, United Kingdom
(continued on page 30A)
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1552 Successful combined bilateral lung volume reduction and coronary artery
bypass grafting surgery: Implications and advantages
Cliff K. Choong, FRCS, FRACS, Jon Naylor, FRCP, Alain Vuylsteke, PhD, FRCA, Ian Hardy, FRCA,
Nicholas Screaton, FRCR, Jo Porter, FRCP, and Michael Davies, FRCP, Cambridge and
Peterborough, United Kingdom
1554 Off-pump revascularization with the use of both internal thoracic arteries
in a 3-year-old child with Kawasaki syndrome
Monika Kowalczyk, MD, Zbigniew Juraszynski, MD, PhD, Piotr Burczynski, MD, PhD,
Grazyna Brzezinska-Rajszys, MD, PhD, and Wanda Kawalec, MD, PhD, Warsaw, Poland
1556 Early stenosis of Medtronic Mosaic porcine valves in the aortic position
Jennifer S. Lawton, MD, Nader Moazami, MD, Michael K. Pasque, MD, Marc R. Moon, MD,
and Ralph J. Damiano, Jr, MD, St Louis, Mo
1557 Tricuspid valve regurgitation after heart transplantation
Daniel Marelli, MD, Fardad Esmailian, MD, Samantha Y. Wong, BS, Jon A. Kobashigawa, MD,
Murray H. Kwon, MD, Ramin E. Beygui, MD, Hillel Laks, MD, Mark D. Plunkett, MD,
Abbas Ardehali, MD, and Richard J. Shemin, MD, Los Angeles, Calif
Brief Communications:
Technical
1560 Membranous tracheoplasty using an azygous vein pedicle graft with
roundabout-field intubation: A novel surgical technique
Mitsuhiro Kamiyoshihara, MD, PhD, Takashi Ibe, MD, Yasuki Iwasaki, MD, Atsushi Takise, MD,
PhD, and Izumi Takeyoshi, MD, PhD, Gunma, Japan
1562 A modified technique of selective lung ventilation through a tracheostomy to
facilitate conservative management of iatrogenic tracheal rupture
Elizabeth Belcher, MRCP, FRCS, Massimo Conti, MD, Peter Goldstraw, FRCS, and
Simon Jordan, FRCS, London, United Kingdom, and Lille, France
1564 Quadruple valve replacement for acute endocarditis
Joerg Seeburger, MD, Heiner Groesdonk, MD, Michael Andrew Borger, MD, PhD,
Denis Merk, MD, Joerg Ender, MD, Volkmar Falk, MD, PhD, Friedrich Wilhelm Mohr, MD, PhD,
and Nicolas Doll, MD, PhD, Leipzig, Germany
1565 A new miniaturized cardiopulmonary bypass system reduces transfusion
requirements during neonatal cardiac surgery: Initial experience in 13
consecutive patients
Andreas Koster, MD, Michael Huebler, MD, Wolfgang Boettcher, ECCP, Mathias Redlin, MD,
Felix Berger, MD, and Roland Hetzer, MD, Berlin, Germany
1568 A novel technique for treatment of mitral valve prolapse/flail
Goran Panic, MD, Miljko Ristic, MD, PhD, Svetozar Putnik, MD, Dejan Markovic, MD,
Ivan Divac, MD, and Uros U. Babic, MD, PhD, Belgrade, Serbia
1570 An improved hemostatic aortic anastomotic technique for nondissected
aortic aneurysms
Robert Saeid Farivar, MD, PhD, and Lawrence H. Cohn, MD, Iowa City, Iowa, and Boston, Mass
(continued on page 32A)
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Letters to the Editor 1572 Reference values: No need for confusion
Nancy A. Obuchowski, PhD, Cleveland, Ohio
1573 Experimental ventricular pressure overload in young animals induces
cardiomyocyte hypertrophy in addition to hyperplasia of contractile and
noncontractile elements of the myocardium
Maria C. D. Abduch, VMD, PhD, Renato S. Assad, MD, PhD, and V. D. Aiello, MD, PhD,
Sa˜o Paulo, Brazil
1573 Clamping the mitral and tricuspid annuli with bipolar devices
Stefano Benussi, MD, PhD, Domenico Corradi, MD, and Ottavio Alfieri, MD, Milan and
Parma, Italy
1574 Reply to the Editor
Manuel Castella´, MD, PhD, Barcelona, Spain
1575 Changes in noninfarcted myocardium explain benefits of on-pump
beating-heart coronary artery bypass grafting for acute
myocardial infarction
Kapilan Varatharajah and Franklin L. Rosenfeldt, MD, FRACS, Prahran, Victoria, Australia
1576 Reply to the Editor
Ken Miyahara, MD, Akio Matsuura, MD, Haruki Takemura, MD, and Shunei Saito, MD,
Ichinomiya, Aichi, Japan
1577 Intraoperative coronary angiography: With or without ischemia?
Augusto D’Onofrio, MD, Giovanni Domenico Cresce, MD, Luigi La Vecchia, MD,
and Alessandro Fabbri, MD, Vicenza, Italy
1577 Reply to the Editor
Eckehard Gerd Kilian, MD, Andres Beiras-Fernandez, MD, Daniel Bauerfeind, MD,
Bruno Reichart, MD, and Peter Lamm, MD, Munich, Germany
1578 Predictor factors of transbronchial needle aspiration diagnostic yield
in sarcoidosis
Alberto Ferna´ndez-Villar, MD, PhD, Virginia Leiro, MD, PhD, and Maribel Botana, MD,
Galicia, Spain
1579 Reply to the Editor
Rocco Trisolini, MD, and Marco Patelli, MD, Bologna, Italy
Notices of Correction 1581 Correction of article by Cerfolio RJ, Bryant AS, Canon CL, Dhawan R,
Eloubeidi MA, entitled Is botulinum toxin injection of the pylorus during
Ivor-Lewis esophagogastrectomy the optimal drainage strategy?
(2009;137:565-72; discussion, 570-2).
1581 Correction of article by Wright CD, Kucharczuk JC, O’Brien SM, Grab JD,
Allen MS. Predictors of major morbidity and mortality after esophageal cancer:
A Society of Thoracic Surgeons General Thoracic Surgery Database risk
adjustment model. (2009;137:587-96; discussion, 596).
1581 Correction of article by Cerfolio RJ, Bryant AS, Eloubeidi MA, Talati AA,
Cerfolio RM, Winokur TS, entitled Change in maximum standardized uptake
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patients with esophageal cancer identifies complete responders.
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